Results
|
6401.
|
Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer. [electronic resource] by
- Wang, You
- Wang, Yingying
- Xiang, Jingying
- Ji, Fang
- Deng, Yan
- Tang, Chunhui
- Yang, Shuyun
- Xi, Qinghua
- Liu, Rong
- Di, Wen
Producer: 20140220
In:
Cancer letters vol. 343
Availability: No items available.
|
|
6402.
|
|
|
6403.
|
|
|
6404.
|
|
|
6405.
|
|
|
6406.
|
Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center. [electronic resource] by
- Mueller, Jennifer J
- Kelly, Amelia
- Zhou, Qin
- Iasonos, Alexia
- Long Roche, Kara
- Sonoda, Yukio
- O'Cearbhaill, Roisin E
- Zivanovic, Oliver
- Chi, Dennis S
- Gardner, Ginger J
Producer: 20170529
In:
Gynecologic oncology vol. 143
Availability: No items available.
|
|
6407.
|
|
|
6408.
|
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer. [electronic resource] by
- Plotti, F
- Montera, R
- Aloisi, A
- Scaletta, G
- Capriglione, S
- Luvero, D
- De Cicco Nardone, C
- Basile, S
- Benedetti Panici, P
- Angioli, R
Producer: 20160620
In:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 42
Availability: No items available.
|
|
6409.
|
A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer. [electronic resource] by
- Morimoto, Akemi
- Nagao, Shoji
- Kogiku, Ai
- Yamamoto, Kasumi
- Miwa, Maiko
- Wakahashi, Senn
- Ichida, Kotaro
- Sudo, Tamotsu
- Yamaguchi, Satoshi
- Fujiwara, Kiyoshi
Producer: 20170328
In:
Japanese journal of clinical oncology vol. 46
Availability: No items available.
|
|
6410.
|
MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression. [electronic resource] by
- Zhang, Jing
- Liu, Lei
- Sun, Yunyan
- Xiang, Jiandong
- Zhou, Dongmei
- Wang, Li
- Xu, Huali
- Yang, Xiaoming
- Du, Na
- Zhang, Meng
- Yan, Qin
- Xi, Xiaowei
Producer: 20180112
In:
Oncotarget vol. 7
Availability: No items available.
|
|
6411.
|
|
|
6412.
|
|
|
6413.
|
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer. [electronic resource] by
- Colombo, Nicoletta
- Formelli, Franca
- Cantù, Maria Grazia
- Parma, Gabriella
- Gasco, Milena
- Argusti, Alessandra
- Santinelli, Alfredo
- Montironi, Rodolfo
- Cavadini, Elena
- Baglietto, Laura
- Guerrieri-Gonzaga, Aliana
- Viale, Giuseppe
- Decensi, Andrea
Producer: 20070620
In:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 15
Availability: No items available.
|
|
6414.
|
|
|
6415.
|
|
|
6416.
|
|
|
6417.
|
|
|
6418.
|
|
|
6419.
|
Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors. [electronic resource] by
- Zhang, Zhenbo
- Liao, Hong
- Chen, Xiaojun
- Zheng, Yu
- Liu, Yingtao
- Tao, Xiang
- Gu, Chao
- Dong, Lingling
- Duan, Tao
- Yang, Yixia
- Liu, Xuelian
- Yu, Yinhua
- Feng, Youji
Producer: 20110615
In:
European journal of obstetrics, gynecology, and reproductive biology vol. 155
Availability: No items available.
|
|
6420.
|
|